Synthesis and applications of a new epoxy-isoindolinone synthesis and applications of a new epoxy-isoindolinone

Article abstract of DOI:10.3987/COM-15-13171

A new epoxy-isoindolinone was stereoselectively synthesized, and its reactions gave several interesting products including a new 6-azabicyclo[3.2.1]octane derivative.

Full text of DOI:10.3987/COM-15-13171

726
HETEROCYCLES, Vol. 91, No. 4, 2015
HETEROCYCLES, Vol. 91, No. 4, 2015, pp. 726 - 737. © 2015 The Japan Institute of Heterocyclic Chemistry
Received, 13th January, 2015, Accepted, 5th February, 2015, Published online, 10th February, 2015
DOI: 10.3987/COM-15-13171
SYNTHESIS AND APPLICATIONS OF A NEW
EPOXY-ISOINDOLINONE
Shang-Shing P. Chou* and Sung-Lin Hsu
Department of Chemistry, Fu Jen Catholic University, New Taipei City 24205,
Taiwan, ROC,
002181@mail.fju.edu.tw
Abstract – A new epoxy-isoindolinone was stereoselectively synthesized, and its
reactions
gave
several
interesting
products
including
a
new
6
-azabicyclo[3.2.1]octane derivative.
INTRODUCTION
1
The isoindole structure has attracted scientists for decades. Within this category, isoindolinone skeletons
are frequently found in bioactive natural products and pharmaceuticals, e.g., indoprofen
2
3
4
(
antiinflammatory), lactonamycin (antibacterial), and hericenone B (platelet aggregation inhibitory)
Figure 1). A variety of synthetic methods for simple and stable isoindolinones has been reported.5
(
O
O
NH
isoindolinone
N
CO H
2
indoprofen
O
O
Me
N
OH
O
OMe
O
Me
O
Me
OH
O
N
O
Me
HO
O
O
O
Ph
MeO
Me
hericenone B
OH
lactonamycin
Figure 1. Isoindolinones structures

HETEROCYCLES, Vol. 91, No. 4, 2015
727
We have recently reported a new method for the synthesis of sulfur-substituted dihydro-isoindolinones
6
7
(
Scheme 1). 5,6-Dihydro-2-pyridone 1, prepared by an aza-Diels–Alder reaction developed by us, could
be converted to the dienyl amide 2 upon treatment with a strong base. Allylation of compound 2 gave the
N-allyled compound 3, which could undergo the intramolecular Diels−Alder (IMDA) reaction in the
presence of base to give the dihydro-isoindolinone product 4 in excellent yield. However, the IMDA of
compound 3 required refluxing in toluene for a long period of time. We thought that the corresponding
sulfone-substituted diene A would probably react faster, because the sulfonyl group should lower the
LUMO of the diene significantly so that an inverse-electron demand Diels−Alder reaction would take
place more effectively.
Scheme 1. Synthesis of isoindolinone derivative 4
RESULTS AND DISCUSSION
Treatment of compound 3 with m-CPBA at room temperature under basic condition yielded directly the
bicyclic sulfone 5 in good yield (Scheme 2). This reaction presumably proceeds through the sulfone
intermediate A, which then undergoes the tandem IMDA reaction to give product 5 directly. Judged by
the reaction conditions, the IMDA reaction of the sulfone intermediate A is indeed much faster than that
of the corresponding diene
3
(Scheme 1). The reaction of compound
5
with
1
,8-diazabicyclo[5.4.0]undec-7-ene (DBU) at room temperature gave the dihydro-isoindolinone 6,
8
together with a small amount of the aromatic compound 7. Compound 6 could also be converted to
compound 7 by heating with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ).

728
HETEROCYCLES, Vol. 91, No. 4, 2015
SPh
SO Ph
2
O
H
DBU (1.5 equiv)
CH Cl , rt, N , 1.5 h
m-CPBA (5 equiv)
N Ts
Na CO (5 equiv)
2
2
2
2
3
N
O
O
o
CH Cl , 0 C to rt, 6 h
H
2
2
Ts
5
(72%)
3
O
DDQ (5 equiv)
N Ts
N Ts
6
7 (55%)
toluene/MeCN (1:1)
reflux, 12 h
6
77% (97:3)
7
Scheme 2. Synthesis of compounds 6 and 7
A plausible mechanism for the formation of compound 6 from compound 5 is shown in Scheme 3.
Deprotonation of compound 5 by DBU at C-5 would give an intermediate B, which is protonated at C-7
to give another intermediate C. Further elimination of benzenesulfinic acid would yield the product 6. Air
oxidation of compound 6 would give the aromatic compound 7.
DBU
SO Ph
PhO S
2
2
O
PhO S
O
O
2
O
H
H
 7
H
HDBU
N Ts
N Ts
N Ts
N Ts
H
5
H
H
H
6
DBU
5
B
C
Scheme 3. Plausible mechanism for the formation of compound 6 from compound 5
Reaction of compound 6 with m-CPBA (3 equiv) at room temperature provided the epoxide 8 (Scheme 4).
9
The stereochemistry of compound 8 was established by X-ray crystallography (Figure 2), which
indicates that the epoxidation proceeds from the same side as the ring junction hydrogen, probably due to
steric effect.
O
O
m-CPBA (3 equiv)
O
N Ts
N Ts
o
CH Cl , N , 0 C to rt, 5 h
2
2
2
H
6
8
(65%)
Scheme 4. Oxidation of compound 6 to epoxide 8

HETEROCYCLES, Vol. 91, No. 4, 2015
729
Figure 2. X-Ray crystal structure of compound 8
Reaction of compound 8 with 10% aqueous sulfuric acid in THF at room temperature gave the trans-diol
(Scheme 5). The stereochemistry of compound 9 was established by X-ray crystallography (Figure 3),9
9
which shows that the hydroxyl group at C-5 is cis to the ring junction hydrogen. We propose that
compound 8 was first protonated at the epoxide group, and then water attacks from the back side of the
o
C-6 because of greater positive charge at this carbon. The reaction of compound 8 with methanol at 60 C
in the presence of one equivalent of concentrated sulfuric acid gave the methoxy alcohol 10. The structure
of compound 10 was elucidated from comparison of its spectral data with those of compound 9.
O
6
HO
excess 10% H SO4
2
N Ts
THF, rt, 17 h
HO
5
O
H
6
9
(42%)
O
N Ts
5
O
H
MeO
HO
conc. H SO (1 equiv)
2
4
8
N Ts
o
MeOH, 60 C, 15 h
H
1
0 (64%)
Scheme 5. Nucleophilic substitution reactions of compound 8
Figure 3. X-Ray crystal structure of compound 9

730
HETEROCYCLES, Vol. 91, No. 4, 2015
Reaction of compound 8 with sodium azide in DMSO at 60 oC gave the unexpected
6
-aminoisoindolinone 11 in 56% yield (Scheme 6), the structure of which was established by X-ray
9
crystallography (Figure 4). A tentative mechanism for its formation is proposed in Scheme 7. Ring
opening of the epoxide of compound 8 at C-6 followed by protonation would give an intermediate D. The
1
0
azido group is then converted by heating in a polar solvent to give a nitrene intermediate E, which is
transformed to an amino intermediate F. Further dehydration and air oxidation would then give the amino
product 11. This reaction could also be carried out in DMF under a similar condition to give product 11 in
3
4% yield.
O
O
NaN (3 equiv)
H N
2
3
O
N Ts
N Ts
o
DMSO, 60 C, 4 h
H
11 (56%)
8
Scheme 6. Substitution reaction of compound 8 to form product 11
Figure 4. X-Ray crystal structure of compound 11
O
O
O
N3
6
N3
N
H O
2
O
N Ts
N Ts
N Ts
HO
5
HO
H
H
E
8
D
O
O
O
H N
2
H N
2
H N
2
[O]
H O
2
H O
2
N Ts
N Ts
N Ts
HO
F
G
11
Scheme 7. Mechanism for the formation of compound 11 from compound 8

HETEROCYCLES, Vol. 91, No. 4, 2015
731
o
If the reaction of compound 8 with sodium azide was carried out in methanol at 60 C, a totally different
product 12 was obtained (Scheme 8), which has the interesting 6-azabicyclo[3.2.1]octane skeleton. The
structure of compound 12 was established by X-ray crystallography (Figure 5).9
O
O
N Ts
HO
NaN (3 equiv)
3
OMe
O
o
H
H
MeOH, 60 C, 3 d
N
H
Ts
8
12 (76%)
Scheme 8. Reaction of compound 8 with NaN to form product 12
3
Figure 5. X-Ray crystal structure of compound 12
A plausible mechanism for the formation of compound 12 from compound 8 is shown in Scheme 9.
Attack of the azide anion at the carbonyl group of compound 8 would give an acyl azide I, which could
undergo an intramolecular substitution reaction with the epoxide group to afford an intermediate J.
N3
O
O
O
N3
N3
O
N Ts
O
N Ts
O
H
H
NTs
8
I
H
O
H
O
H
O
H
HO
O
H
HO
MeOH
OMe
OMe
N3
N3
H
H
N
N
N
Ts
Ts
Ts
J
K
12
Scheme 9. Mechanism for the formation of compound 12 from compound 8 and NaN
3

732
HETEROCYCLES, Vol. 91, No. 4, 2015
Protonation would then give an alcohol intermediate K. Further substitution of the azido group by the
methoxide ion would then give the product 12. It is interesting to note that the azide anion exhibits two
different reaction pathways with compound 8 in DMSO and MeOH (Scheme 7 and Scheme 9,
respectively).
We found that the reaction of compound 8 with NaOMe in methanol also afforded product 12, albeit in
much lower yield (Scheme 10).
O
O
N Ts
HO
NaOMe (3 equiv)
OMe
O
o
H
H
MeOH, 60 C, 3 d
N
H
Ts
8
12 (38%)
Scheme 10. Reaction of compound 8 with NaOMe to form product 12
A different mechanism is proposed (Scheme 11). The reaction of compound 8 with NaOMe would give
the ring opening intermediate L, which could undergo an intramolecular substitution reaction with the
epoxide group to afford the intermediate M. Protonation would then give the product 12.
O
O
H
O
O
H
HO
OMe
O
MeOH
OMe
OMe
OMe
O
N Ts
O
H
H
H
N
N
NTs
Ts
Ts
8
L
M
12
Scheme 11. Mechanism for the formation of compound 12 from compound 8 and NaOMe
The 6-azabicyclo[3.2.1]octane skeleton is found in a wide variety of naturally occurring and
pharmacologically active molecules. Some examples include natural products such as the GABA
A
1
1
12
receptor antagonist securinine and analgesic aphanorphine.
N
NH
NMe
H
O
HO
6-azabicyclo[3.2.1]octane
O
(
-)-aphanorphine
securinine
Figure 6. 6-Azabicyclo[3.2.1]octane structures

HETEROCYCLES, Vol. 91, No. 4, 2015
733
CONCLUSION
Bicyclic sulfone 5 was prepared directly from dienyl amide 3 by tandem oxidation and intramolecular
Diels−Alder reaction. Treatment of compound 5 with DBU gave the dihydro-isoindolinone 6, which was
oxidized by m-CPBA to give the epoxy-isoindolinone 8. Nucleophilic substitution reactions of compound
8
gave products 9-12. Compound 12 has a very interesting 6-azabicyclo[3.2.1]octane skeleton.
EXPERIMENTAL
Melting points were determined with a SMP3 melting apparatus. Infrared spectra (ATR) were recorded
1
13
with a Perkin Elmer 100 series FTIR spectrophotometer. H and C NMR spectra were mostly recorded
on a Bruker Avance 300 spectrometer operating at 300 and at 75 MHz, respectively. Chemical shifts ()
are reported in parts per million (ppm) and the coupling constants (J) are given in Hertz. High resolution
mass spectra (HRMS) were measured with a mass spectrometer Finnigan/Thermo Quest MAT 95XL.
Flash column chromatographic purifications were performed using Merck 60 H silica gel.
cis-7-(Phenylsulfonyl)-2-tosyl-2,3,3a,4,5,7a-hexahydro-1H-isoindol-1-one (5)
To a solution of compound 3 (115.8 mg, 0.29 mmol) and sodium carbonate (153.7 mg, 1.45 mmol) in
3
o
CH
2
Cl
2
(11 cm ) at 0 C was added in portions of m-CPBA (70% in H O, 357.5 mg, 1.45 mmol). The
2
mixture was stirred at room temperature for 6 h, and then sequentially washed with saturated aq. sodium
3
3
thiosulfate solution (5 cm x 2) and saturated aq. sodium bicarbonate solution (5 cm x 2). The organic
layer was dried (MgSO ), evaporated under vacuum, and the crude product was purified by flash
chromatography using EtOAc–hexane (1 : 1) as eluent to give 5 (90.4 mg, 72%) as a white solid; mp
4
o
-1
-1
1
85.6－186.1 C; νmax (film/cm ) 3060, 2951, 2911, 2857, 1742, 1359, 1306, 1169, 1142, 1088 cm ; δ
300 MHz; CDCl ) 7.94 (2H, d, J = 7.2 Hz), 7.82 (2H, d, J = 8.4 Hz), 7.64－7.58 (1H, m), 7.54－7.48
2H, m), 7.31 (2H, d, J = 8.1 Hz), 7.18－7.12 (1H, m), 3.93 (1H, dd, J = 5.1, 9.9 Hz), 3.82 (1H, d, J = 6.6
H
(
(
3
Hz), 3.66 (1H, d, J = 9.9 Hz), 2.45 (3H, s), 2.39－2.35 (3H, m), 1.80－1.75 (1H, m), 1.33－1.25 (1H, m);
δ
C
(75 MHz; CDCl
3
) 168.8, 145.2, 143.3, 14.2, 137.2, 134.7, 133.2, 129.7, 128.7, 128.6, 127.9, 50.7, 43.1,
+
3
4
1.0, 24.7, 22.3, 21,6; HRMS (EI) Found: M , 431.0865. C21
H21NO
5
S
2
requires 431.0861；EI-HRMS m/z
31.0865.
2
-Tosyl-2,3,3a,4-tetrahydro-1H-isoindol-1-one (6)
3
To a solution of compound 5 (151.0 mg, 0.35 mmol) in CH
2
Cl
2
(15 cm ) under nitrogen at room
temperature was added slowly DBU (160 mg, 1.05 mmol). After stirring at room temperature for 1.5 h,
3
the reaction mixture was washed with saturated aq. ammonium chloride solution (10 cm x 2). The

734
HETEROCYCLES, Vol. 91, No. 4, 2015
3
aqueous solution was extracted with CH
2
Cl
2
(10 cm x 3). The combined organic solution was dried
(
MgSO4) and evaporated under vacuum. The crude product was purified by flash chromatography using
o
EtOAc–hexane (1 : 2) as eluent to give 6 (77.9 mg, 77%) as a white solid; mp 156.3－158.7 C; νmax
-1
(
film/cm ) 2928, 1720, 1660, 1596, 1566, 1358, 1233, 1169, 1088, 1056, 704, 661; δ
.99 ( 2H, d, J = 8.2 Hz), 7.34 (2H, d, J = 8.2 Hz), 6.79 (1H, d, J = 3.6 Hz), 6.23－6.13 (2H, m), 4.36 (1H,
t, J = 9.3 Hz), 3.28 (1H, dd, J = 9.0, 8.4 Hz), 2.96－2.85 (1H, m), 2.62-2.51 (1H, m), 2.42 (3H, s), 2.03－
H
(300 MHz; CDCl
3
)
7
1
2
.90 (1H, m); δ
C
(75 MHz; CDCl ) 164.8, 145.1, 135, 132, 129.9, 129.5, 128.1, 127.9, 124.6, 51.9, 29.2,
3
+
1
7.4, 21.5. HRMS (FAB) Found: M , 289.0769. C15
H
15NO S requires 289.0773. The H NMR of
3
compound 6 showed the presence of about 3% of compound 7 which cannot be separated by
recrystallization or chromatography.
2
-Tosylisoindolin-1-one (7)
A mixture of compound 6 (12.7 mg, 0.044 mmol) and DDQ (49.94 mg, 0.22 mmol) in toluene (5 cm3)
3
and MeCN (5 cm ) was refluxed under nitrogen for 12 h. The solvent was evaporated under vacuum, and
the crude product was purified by flash chromatography using EtOAc–hexane (1 : 2) as eluent to give 7
(
6.9 mg, 55%) as a white solid.8
(
3aR*,5R*,6R*)-2-Tosyl-2,3,3a,4,5,6-hexahydro-1H-5,6-epoxy-isoindol-1-one (8)
3
o
To a solution of compound 6 (26.2 mg, 0.091 mmol) in CH
2
Cl (2 cm ) at 0 C was added in portions of
2
m-CPBA (70% in H O, 67 mg, 0.273 mmol). The mixture was stirred at room temperature for 5 h, diluted
2
(30 cm ), and then sequentially washed with saturated aq. sodium thiosulfate solution (5 cm3
3
with CH
2
Cl
2
3
x 2) and saturated aq. sodium bicarbonate solution (5 cm x 2). The organic layer was dried (MgSO
4
),
evaporated under vacuum, and the crude product was purified by flash chromatography using
o
EtOAc–hexane (1 : 1) as eluent to give 8 (17.9 mg, 65%) as a white solid; mp 173.5－175.0 C; νmax
-1
(
film/cm ) 3046, 2992, 2953, 2869, 1717, 1667, 1569, 1481, 1358, 1335, 1227, 1212, 1172, 1088, 1040,
49, 922, 822, 809, 772, 736, 663; δ (300 MHz; CDCl ) 7.93 (2H, d, J = 8.2 Hz), 7.34 (2H, d, J = 8.2
Hz), 6.89 (1H, t, J = 3.6 Hz), 4.24 (1H, t, J = 9.4 Hz), 3.61－3.49 (1H, m), 3.48 (1H, t, J = 3.9 Hz), 3.37
9
H
3
(1H, dd, J = 9.4, 8.2 Hz), 2.95－2.88 (1H, m), 2.65 (1H, ddd, J = 2.4, 8.2, 14.1 Hz), 2.43 (3 H, s), 1.35
(1H, dd, J = 11.7, 14.1 Hz); δ
C
(75 MHz; CDCl
3
) 164.5, 145.3, 136.2, 134.9, 129.7, 129.5, 128.1, 53.9,
+
5
0.6, 46.2, 29.6, 25.7, 21.6. HRMS (FAB) Found: M , 305.0727. C15
H
15NO S requires 305.0722.
4
(
3aR*,5R*,6R*)-5,6-Dihydroxy-2-tosyl-2,3,3a,4,5,6-hexahydro-1H-isoindol-1-one (9)
3
3
A solution of compound 8 (26 mg, 0.085 mmol) and 10% H
2
SO
4
(10 cm ) in THF (5 cm ) was stirred at

HETEROCYCLES, Vol. 91, No. 4, 2015
735
room temperature under nitrogen for 17 h. The solvent was evaporated under vacuum, and 5% NaOH (5
3
3
cm ) and saturated aq. sodium bicarbonate solution (5 cm ) were added. The mixture was extracted with
3
EtOAc (10 cm x 3), dried (MgSO
4
) and evaporated under vacuum. The crude product was purified by
flash chromatography using EtOAc as eluent to give 9 (11.5 mg, 42%) as a white solid; mp 174.6－176.8
oC; νmax (film/cm ) 3353, 2922, 2852, 1725, 1678, 1457, 1361, 1166, 1089, 1022, 813, 730, 662; δ
-1
(300
H
MHz; CDCl
3
) 7.8 (2H, d, J = 8.2 Hz), 7.31 (2H, d, J = 8.2 Hz), 6.38 (1H, t, J = 2.6 Hz), 4.12 (1H, t, J =
8.9 Hz), 3.89－3.85 (2H, m), 3.22－3.18 (1H, m), 3.16 (1H, d, J = 9.1 Hz), 2.99－2.95 (1H, m), 2.33 (3H,
s), 1.98－1.91 (1H, m), 1.32 (1H, ddd, J = 1.9, 11.2, 13.0 Hz); δ
C
(75 MHz; CDCl
3
) 167.6, 147.0, 137.2,
+
1
36.4, 132.7, 130.9, 129.2, 70.6, 68.6, 52.6, 30.4, 29.1, 21.7. HRMS (FAB) Found: M , 323.0827.
C
15
H
17NO S requires 323.0827.
5
(
3aR*,5R*,6R*)-5-Hydroxy-6-methoxy-2-tosyl-2,3,3a,4,5,6-hexahydro-1H-isoindol-1-one (10)
A solution of compound 8 (11.1 mg, 0.036 mmol) and concentrated H
2
SO (2 uL, 0.036 mmol) in MeOH
4
3
(
5 cm ) was stirred at room temperature under nitrogen for 15 h. To the reaction mixture was added 5%
3
3
NaOH aqueous solution (5 cm ), and was then extracted with CHCl (5 cm x 3). The organic solution
3
3
was extracted with EtOAc (10 cm x 3), dried (MgSO
4
) and evaporated under vacuum to give 10 (6.8 mg,
o
-1
5
1
5%) as a white solid; mp 149.6－152.4 C; νmax (film/cm ) 3475, 2922, 2849, 1727, 1596, 1358, 1186,
089, 814, 736, 663; δ
H
(300 MHz; CDCl ) 7.91 (2H, d, J = 8.4 Hz), 7.31 (2H, d, J = 8.4 Hz), 6.61 (1H, t,
3
J = 3.2 Hz), 4.24 (1H, t, J = 8.9 Hz), 4.13 (1H, d, J = 2.2 Hz), 3.60 (1H, dd, J = 7.9, 3.4 Hz), 3.42 (3H, s),
.23 (1H, t, J = 9.1 Hz), 3.13－3.07 (1H, m), 2.42 (3H, s), 2.08－2.02 (1H, m), 1.77 (2H, s), 1.41 (1H,
3
ddd, J = 15.8, 10.7, 2.5 Hz); δ
C
(75 MHz; d-MeOH) 167.4, 147.1, 138.1, 136.5, 131.1, 130.6, 129.3, 78.2,
+
6
7.4, 67.4, 58.4, 30.5, 29.9, 21.7. HRMS (FAB) Found: M , 337.0988. C16
H
19NO S requires 337.0984
5
6
-Amino-2-tosylisoindolin-1-one (11)
A mixture of compound 8 (20.1 mg, 0.067 mmol) and NaN
3
(12.9 mg, 0.198 mmol) in DMSO or DMF (2
3
o
cm ) was heated under nitrogen at 60 C for 4 h. The solvent was removed under vacuum, saturated aq.
3
3
ammonium chloride solution (5 cm ) was added, and the mixture was extracted with CH
The combined organic solution was dried (MgSO ), evaporated under vacuum, and the crude product was
purified by flash chromatography using EtOAc–hexane (1 : 1) as eluent to give 11 (12 mg, 56%) as a
2
Cl (10 cm x 3).
2
4
o
-1
white solid; mp 248.6 C (decomp.); νmax (film/cm ) 3373, 2922, 1719, 1633, 1503, 1354, 1166, 1086,
14, 665; δ (300 MHz; CDCl ) 8.01 (2H, d, J = 8.3 Hz), 7.33 (2H, d, J = 8.3 Hz), 7.22 (1H, d, J = 8.2
Hz), 7.01 (1H, d, J = 2.1 Hz), 6.92 (1H, dd, J = 8.2, 2.2 Hz), 4.79 (2H, s), 3.88 (2H, br s), 2.41 (3H, s); δ
75 MHz; CDCl ) 166.5, 147.3, 145.1, 135.6, 131.4, 130.9, 129.8, 128.2, 124.0, 121.5, 109.3, 49.6, 21.7.
8
H
3
C
(
3

736
HETEROCYCLES, Vol. 91, No. 4, 2015
+
HRMS (FAB) Found: M , 302.0730. C15
H
14
N
2
3
O S requires 302.0725.
(
1R*,4S*,5S*)-Methyl 4-hydroxy-6-tosyl-6-azabicyclo[3.2.1]oct-2-ene-2-carboxylate (12)
3
A mixture of compound 8 (20 mg, 0.066 mmol) and NaN (12.9 mg, 0.198 mmol) in MeOH (10 cm ) was
3
o
heated in a sealed tube at 60 C for 3 d. The solvent was removed under vacuum, 5% NaOH aqueous
3
3
solution (5 cm ) was added, and the mixture was extracted with CHCl (10 cm x 3). The combined
3
organic solution was dried (MgSO
4
), evaporated under vacuum to give 12 (16.7 mg, 76%) as a white
o
-1
solid; mp 155.6－157.3 C; νmax (film/cm ) 3481, 2953, 1714, 1438, 1337, 1252, 1085, 1042, 816, 685,
6
62; δ
H
(300 MHz; CDCl ) 7.70 (2H, d, J = 8.3 Hz), 7.30 (2H, d, J = 8.3 Hz), 6.72 (1H, dd, J = 4.0, 1.5
3
Hz), 4.38 (1H, t, J = 3.5 Hz), 4.07 (1H, t, J = 1.6 Hz), 3.74 (3H, s), 3.27 (1H, t, J = 4.0 Hz), 3.23 (1H, dd,
J = 1.2, 8.8 Hz), 3.04 (1H, dd, J = 4.5, 8.8 Hz), 2.39 (3H, s), 1.72 (1H, d, J = 11.6 Hz), 1.21-1.19 (1H, m);
δ
C
(75 MHz; CDCl
3
) 166.0, 143.7, 136.6, 136.3, 135.1, 129.8, 127.1, 68.5, 59.9, 53.1, 52.1, 34.6, 29.0,
+
2
1.5. HRMS (FAB) Found: M , 337.0984. C16
H
19NO S requires 337.0984.
5
ACKNOWLEDGEMENTS
Financial support of this work by the Ministry of Science and Technology of the Republic of China (NSC
01-2113-M-030-001-MY2) is gratefully acknowledged.
1
REFERENCES AND NOTES
1
2
.
.
For a recent review, see: K. Speck and T. Magauer, Beilstein J. Org. Chem., 2013, 9, 2048.
A. Buttinoni, M, Ferrari, M. Colombo, and R. J. Ceserani, Pharm. Pharmacol., 1983, 35, 603; M. R.
Lunn, D. E. Root, A. M. Martino, S. P. Flaherty, B. P. Kelley, D. D. Coovert, A. H. Burghes, N. T.
Man, G. E. Morris, J. Zhou, E. J. Androphy, C. J. Sumner, and B. R. Stockwell, Chem. Biol., 2004,
1
1, 1489; E. C. Wolstencroft, V. Mattis, A. A. Bajer, P. J. Young, and C. L. Lorson, Hum. Mol.
Genet., 2005, 14, 1199; F. Sangiuolo, A. Botta, A. Filareto, P. Spitalieri, and G. Novelli, Cur.
Genom., 2006, 7, 381.
3
.
N. Matsumoto, T. Tsuchida, M. Maruyama, R. Sawa, N. Kinoshita, Y. Homma, Y. Takahashi, H.
Iinuma, H. Naganawa, T. Sawa, M. Hamada, and T. Takeuchi, J. Antibiot., 1996, 49, 953; N.
Matsumoto, T. Tsuchida, H. Nakamura, R. Sawa, Y. Takahashi, H. Naganawa, H. Iinuma, T. Sawa,
T. Takeuchi, and M. Shiro, J. Antibiot., 1999, 52, 276; N. Matsumoto, T. Tsuchida, M. Maruyama,
N. Kinoshita, Y. Homma, H. Iinuma, T. Sawa, M. Hamada, and T. Takeuchi, J. Antibiot., 1999, 52,
2
69.
4
.
H. Kawagishi, M. Ando, and T. Mizuno, Tetrahedron Lett., 1990, 31, 373; K. Mori, H. Kikuchi, Y.
Obara, M. Iwashita, Y. Azumi, S. Kinugasa, S. Inatomi, Y. Oshima, and N. Nakahata, Phytomed.,

HETEROCYCLES, Vol. 91, No. 4, 2015
737
2
010, 17, 1082.
5
.
S. Adachi, M. Onozuka, Y. Yoshida, M. Ide, Y. Saikawa, and M. Nakata, Org. Lett., 2014, 16, 358
and references cited therein.
6
.
.
S. S. P. Chou and C. J. J. Wu, Tetrahedron, 2012, 68, 1185.
7
S. S. P. Chou and C. C. Hung, Tetrahedron Lett., 2000, 41, 8323; S. S. P. Chou and C. C. Hung,
Synthesis, 2001, 2450.
8
.
.
S. Kagabu, K. Saito, H. Watanabe, H. Takahashi, and K. Wada, Bull. Chem. Soc. Jpn., 1991, 64, 106;
A. J. Catino, J. M. Nichols, H. Choi, S. Gottipamula, and M. P. Doyle, Org. Lett., 2005, 7, 5167; T.
Morimoto, M. Fujioka, K. Fuji, K. Tsutsumi, and K. Kakiuchi, J. Organomet. Chem., 2007, 692, 625;
B. P. Babu, Y. Endo, and J. E. Bäckvall, Chem. Eur. J., 2012, 18, 11524; M. Fujioka, T. Morimoto,
T. Tsumagari, H. Tanimoto, Y. Nishiyama, and K. Kakiuchi, J. Org. Chem., 2012, 77, 2911.
Crystallographic data (excluding structure factors) for compounds 8, 9, 11, and 12 in this paper has
been deposited with the Cambridge Crystallographic Data Centre as supplementary publication
CCDC 1042917－1042919 and 1043256, respectively. Copies of the data can be obtained, free of
9
charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax:
+
44-(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).
0. E. F. V. Scriven, ed., Azides and Nitrenes: Reactivity and Utility, Academic Press: Orlando, FL.,
984.
1
1
1
1. S. Saito, K. Kotera, N. Shigematsu, A. Ide, N. Sugimoto, Z. Horii, M. Hanaoka, Y. Yamawaki, and
Y. Tamura, Tetrahedron, 1963, 19, 2085; Z. Horii, M. Ikeda, Y. Yamawaki, Y. Tamura, and S. Saito,
Tetrahedron, 1963, 19, 2101.
1
2. N. Gulavita, A. Hori, Y. Shimizu, P. Laszlo, and J. Clardy, Tetrahedron Lett., 1988, 29, 4381.